| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 836.30M | 746.30M | 602.30M | 311.80M | 190.60M |
| Gross Profit | 786.40M | 746.30M | 594.10M | 311.80M | 131.50M |
| EBITDA | 119.10M | 127.90M | 192.70M | -36.10M | -41.40M |
| Net Income | 116.80M | 125.60M | 190.80M | -43.90M | -42.00M |
Balance Sheet | |||||
| Total Assets | 2.33B | 1.91B | 1.50B | 1.57B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 339.20M | 313.20M | 199.80M | 112.90M | 67.50M |
| Total Debt | 800.00K | 1.60M | 2.30M | 2.40M | 2.90M |
| Total Liabilities | 1.22B | 855.00M | 508.80M | 754.00M | 353.60M |
| Stockholders Equity | 1.10B | 1.05B | 987.40M | 814.40M | 981.20M |
Cash Flow | |||||
| Free Cash Flow | 361.60M | 406.60M | 308.70M | 202.90M | 47.30M |
| Operating Cash Flow | 361.60M | 407.30M | 309.40M | 203.20M | 48.70M |
| Investing Cash Flow | -269.20M | -219.70M | -148.70M | -77.90M | -1.01B |
| Financing Cash Flow | -75.70M | -69.70M | -73.80M | -79.80M | -30.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £612.11M | 7.04 | 11.14% | 7.08% | 15.83% | -93.41% | |
76 Outperform | £573.05M | 5.68 | 30.00% | 8.73% | 7.71% | -7.39% | |
74 Outperform | £851.25M | 8.25 | 7.11% | 2.70% | -4.38% | ― | |
72 Outperform | £213.84M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | £148.98M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% | |
46 Neutral | £528.93M | -2.93 | -9.28% | ― | -15.79% | -211.91% |